Ranked #1,779 of 8,699 institutional investors
Kynam Capital Management, LP
Princeton, NJ
$1.57B
US stock portfolio at live prices · today +$11.2M (+0.72%)
Market closed. Prices as of Nov 20, 8:11 AM ET
- Value at quarter end (Q3 2026)
- $1.81B
- Change from Q2 2026
- −$3.3M (−0.18%)
- Positions
- 31 · 4 new, 2 sold out
- Filed
- Nov 16, 2026
Not counted in the ranking: none$128M of holdings we could not match to a US listing are included at their reported quarter-end value.
Holdings
Q3 2026 13F, live pricesVRDN 12.3%PCVX 9.70%LEGN 9.39%CLDX 9.02%COGT 6.70%
| Stock | Shares | Value, live | % of portfolio | vs Q2 2026 |
|---|---|---|---|---|
| VRDN Viridian Therapeutics, Inc. | 6,148,000 | $193M | 12.3% | Reduced −5% |
| PCVX Vaxcyte, Inc. | 2,607,964 | $152M | 9.70% | Reduced −11% |
| LEGN Legend Biotech Corporation | 9,154,389 | $147M | 9.39% | Added +205% |
| CLDX Celldex Therapeutics, Inc. | 5,066,051 | $142M | 9.02% | Reduced −5% |
| COGT Cogent Biosciences, Inc. | 3,792,289 | $105M | 6.70% | Added +3% |
| TVTX Travere Therapeutics, Inc. | 2,000,000 | $96.6M | 6.15% | Unchanged |
| BEAM Beam Therapeutics Inc. | 3,933,894 | $82.4M | 5.25% | Added +38% |
| VERA Vera Therapeutics, Inc. | 3,000,000 | $80.3M | 5.11% | Added +4% |
| SNDX Syndax Pharmaceuticals, Inc. | 8,150,959 | $74.4M | 4.74% | Added +1% |
| MBX MBX Biosciences, Inc. | 934,799 | $49.9M | 3.18% | Unchanged |
| RLAY Relay Therapeutics, Inc. | 2,751,500 | $43.8M | 2.79% | Reduced −17% |
| CTMX CytomX Therapeutics, Inc. | 21,140,726 | $43.3M | 2.76% | Reduced −3% |
| IMCR Immunocore Holdings plc | 1,375,000 | $36.6M | 2.33% | Unchanged |
| SMMT Summit Therapeutics Inc. | 3,000,000 | $31.7M | 2.02% | Added +150% |
| CGEM Cullinan Therapeutics, Inc. | 3,114,132 | $28.2M | 1.80% | Unchanged |
| BCRX BioCryst Pharmaceuticals, Inc. | 2,522,660 | $18.5M | 1.18% | Unchanged |
| BNR Burning Rock Biotech Limited | 1,238,563 | $16.5M | 1.05% | Unchanged |
| NRIX Nurix Therapeutics, Inc. | 1,194,757 | $16.2M | 1.04% | Unchanged |
| SRZN Surrozen, Inc. | 486,252 | $14.9M | 0.95% | New |
| XENE Xenon Pharmaceuticals Inc. | 280,000 | $10.5M | 0.67% | New |
| ALEC Alector, Inc. | 4,308,494 | $9.9M | 0.63% | Added +13% |
| EVMN Evommune Inc | 1,200,000 | $8.7M | 0.55% | New |
| STRO Sutro Biopharma, Inc. | 872,558 | $7.6M | 0.48% | Unchanged |
| PRLD Prelude Therapeutics Incorporated | 2,311,955 | $7.5M | 0.48% | Reduced −4% |
| PBLS Parabilis Medicines, Inc. | 250,000 | $6.9M | 0.44% | Unchanged |
| GERN Geron Corporation | 6,836,318 | $6.2M | 0.40% | Unchanged |
| AMRN Amarin Corporation plc | 532,982 | $6.0M | 0.38% | Unchanged |
| HROW Harrow, Inc. | 124,655 | $4.0M | 0.26% | New |
| ENGN enGene Therapeutics Inc. | 457,855 | $806K | <0.1% | Unchanged |
| CRBU Caribou Biosciences, Inc. | 2,503,302 | $777K | <0.1% | Unchanged |
| TRAW Traws Pharma, Inc. | 84,400 | $19K | <0.1% | Unchanged |